Organogenesis Holdings Inc is a leading regenerative medicine company that focuses on developing and commercializing advanced wound care and surgical biologics products
The company specializes in innovative solutions that support the healing of complex wounds and surgical procedures, leveraging its expertise in cellular and tissue-based therapies. Organogenesis is committed to improving patient outcomes by offering cutting-edge products that foster healing and recovery, thereby addressing unmet medical needs in the healthcare sector. Through a combination of research, development, and clinical support, the company aims to enhance the quality of care provided to patients across various medical disciplines.
Shares of Reneo Pharmaceuticals, Inc. (NASDAQRPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share. Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Gainers Bionomics Limited (NASDAQBNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.
